Epidemiology, Precursors, and Markers of Malignant Melanoma
R.M. MACKIE, W. Bergman(Leiden University Medical Center), Anthony J. Swerdlow(Institute of Cancer Research), L Illig(Justus-Liebig-Universität Gießen), D. J. Ruiter(Radboud University Nijmegen), Alfred W. Kopf, Richard P. Gallagher(BC Cancer Agency), Mark Elwood(University of Otago), Darrell S. Rigel(The University of Texas Southwestern Medical Center), C.J. O’Doherty(University of Glasgow), J. Clark(University of Glasgow), J. English(University of Glasgow), M. C. Mihm(St George's Hospital), J. A. A. Hunter(University of Glasgow), R. J. Friedman(New York University), A. B. Ackerman(Corner House), David Hole(Conservation International), Edward Heilman(New York University), G. Rassner
Cited by 0
Related Papers
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
|Nature Genetics|1994|850
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
|JNCI Journal of the National Cancer Institute|2015|570
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
|Journal of Clinical Oncology|2016|517
<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
|Journal of Clinical Oncology|2011|433